4,883 Shares in HCA Healthcare, Inc. $HCA Purchased by Paralel Advisors LLC

Posted by Stanley Muller on Sep 7th, 2026

Paralel Advisors LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,883 shares of the company’s stock, valued at approximately $1,904,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. BlackRock Inc. bought a new position in shares of HCA Healthcare in the second quarter worth $5,069,974,000. Norges Bank purchased a new stake in HCA Healthcare during the 4th quarter worth about $1,262,513,000. Legal & General Group Plc purchased a new position in HCA Healthcare during the 2nd quarter valued at about $410,992,000. Jupiter Topco LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth about $371,138,000. Finally, Life Cycle Investment Partners Ltd purchased a new position in HCA Healthcare during the fourth quarter valued at approximately $374,037,000. 62.73% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Barclays reduced their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Weiss Ratings cut HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research report on Monday, July 27th. Finally, JPMorgan Chase & Co. dropped their target price on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research report on Thursday, August 20th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $462.64.

Check Out Our Latest Research Report on HCA

HCA Healthcare Trading Down 0.0%

HCA opened at $404.95 on Monday. The stock has a market capitalization of $87.67 billion, a P/E ratio of 13.56, a PEG ratio of 1.33 and a beta of 1.10. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The stock has a 50-day moving average price of $403.35 and a 200-day moving average price of $436.82.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.84 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.45%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.